4-Chlorobenzenesulfonyl chloride structure
|
Common Name | 4-Chlorobenzenesulfonyl chloride | ||
|---|---|---|---|---|
| CAS Number | 98-60-2 | Molecular Weight | 211.066 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 272.8±13.0 °C at 760 mmHg | |
| Molecular Formula | C6H4Cl2O2S | Melting Point | 50-52 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 118.8±19.8 °C | |
| Symbol |
GHS05 |
Signal Word | Danger | |
| Name | 4-Chlorobenzenesulfonyl chloride |
|---|---|
| Synonym | More Synonyms |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 272.8±13.0 °C at 760 mmHg |
| Melting Point | 50-52 °C(lit.) |
| Molecular Formula | C6H4Cl2O2S |
| Molecular Weight | 211.066 |
| Flash Point | 118.8±19.8 °C |
| Exact Mass | 209.930908 |
| PSA | 42.52000 |
| LogP | 2.84 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.569 |
| Water Solubility | INSOLUBLE |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | C |
| Risk Phrases | R34:Causes burns. R37:Irritating to the respiratory system. |
| Safety Phrases | S26-S28-S36/37/39-S45 |
| RIDADR | UN 3261 8/PG 2 |
| WGK Germany | 2 |
| RTECS | DB8925000 |
| Packaging Group | II |
| Hazard Class | 8 |
| HS Code | 29049020 |
| Precursor 8 | |
|---|---|
| DownStream 10 | |
| HS Code | 2904909090 |
|---|---|
| Summary | HS:2904909090 sulphonated, nitrated or nitrosated derivatives of hydrocarbons, whether or not halogenated VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
|
Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents.
Eur. J. Med. Chem. 90 , 428-35, (2015) Hepatitis B virus (HBV) is a causative reagent that frequently causes progressive liver diseases, leading to the development of acute, chronic hepatitis, cirrhosis, and eventually hepatocellular carci... |
|
|
Preparation of functionalized 3, 4-pyridynes via 2-magnesiated diaryl sulfonates. Lin W, et al.
Tetrahedron 63(13) , 2787-2797, (2007)
|
| 4-chloro-benzenesulfonylchlorid |
| 4-CHLOROBENZENE-1-SULPHONYL CHLORIDE |
| 4-CHLOROBENZENESULFONYL |
| 4-CHLORO-BENZENESULFONYL CHLORIDE |
| CHLOROBENZENESULFONYL CHLORIDE |
| 4-CHLOROBENZENE SULFONYL CHLORIDE |
| 4-Chlorobenzenesulfonyl chloride |
| 4-CHOROBENZENESULPHONYL CHLORIDE |
| MFCD00007439 |
| 4-Chlorobenzenesulfo |
| p-chlorophenylsulfonyl chloride |
| 4-Chlorobenzene |
| p-chlorobenzenesulfonyl chloride |
| p-Chlorobenzenesulfonylchlori |
| 4-CHLOROBENZENESULPHONYL CHLORIDE |
| 4-Chlorophenylchloro sulfone |
| 4-CHLORO BENZENE SULPHONYL CHLORIDE |
| EINECS 202-685-3 |
| Benzenesulfonyl chloride, 4-chloro- |
| 4-Cl-PhSO2Cl |
| 4-Chlorophenylsulfonyl Chloride |
| 4-chlorobenzene-1-sulfonyl chloride |
| p-Chlorbenzensulfochlorid |
| p-Chlorobenzenesulfochloride |
| p-chloro-benzenesulfonylchlorid |
| 4-chlorobenzenesulfonylchloride |
| p-chlorophenylSO2Cl |